Form 4: Molina Healthcare Director Receives Equity Award
Insider Transaction Report
Molina Healthcare, Inc. reports a director, Stephen H. Lockhart, received an equity award of 405 common shares valued at $135.82 per share on April 1, 2026.
Summary
- Stephen H. Lockhart, a Director at Molina Healthcare, Inc. (MOH), was granted 405 shares of common stock on April 1, 2026.
- This grant is part of the Issuer's 2025 Equity Incentive Plan, awarded for services rendered as a Director.
- The annual equity award for directors is set at $220,000, with one-quarter ($55,000) granted on the first day of each quarter.
- The number of shares granted is determined by the closing price of MOH common stock on the grant date.
- On April 1, 2026, the closing price was $135.82, resulting in the 405-share grant.
- Following this transaction, Mr. Lockhart beneficially owns 4,147 shares of common stock directly.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral filing, as it reports a routine equity grant to a director as part of a pre-established compensation plan.
Positives
- Director Lockhart received an equity award, indicating continued investment in and alignment with the company's performance.
- The award is part of a structured annual equity grant program for directors, suggesting a consistent compensation strategy.
- The grant is based on the company's stock price, linking director compensation to shareholder value.
Future Outlook
The filing does not contain forward-looking statements or guidance. It reports a completed transaction.
Industry Context
StockSavvy.ai notes that equity awards to directors are a common practice in the healthcare industry to align executive and director interests with those of shareholders and incentivize long-term performance.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Equity Incentive Plan | Grant of stock under the Issuer's 2025 Equity Incentive Plan. | 04/01/2026 | Standard practice for director compensation, aligning incentives. |
| Director Compensation Structure | Annual equity award for directors set at $220,000, with quarterly grants based on stock price. | Ongoing | Provides a consistent and performance-linked compensation framework for directors. |
Related Party Transactions
- The transaction involves a grant of equity to a director (Stephen H. Lockhart) under the company's equity incentive plan, which is a standard related-party transaction for compensation purposes.
Stakeholder Impact
- Shareholders: The equity grant aligns director interests with shareholder value, as the award's value is tied to the company's stock price. Dilution is minimal given the number of shares granted.
- Employees: This filing does not directly impact employees, but it reflects the company's compensation practices for its leadership.
- Management: The grant reinforces the compensation structure for directors.
Key Dates
| Date | Description |
|---|---|
| 05/06/2021 | Date of execution for the Limited Power of Attorney for Section 16(a) Filings by Stephen H. Lockhart, MD. |
| 04/01/2026 | Transaction date for the grant of common stock to Director Stephen H. Lockhart and the closing price date used for the grant calculation. |
| 04/02/2026 | Date of signature for the Form 4 filing. |
Keywords
Molina Healthcare, MOH, Form 4, SEC Filing, Director Compensation, Equity Award, Stock Grant, Beneficial Ownership, Insider Trading, Securities Exchange Act
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.